These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [The dobutamine-dopamine combination versus amrinone in congestive heart failure with a marked edematogenic sign complicated by functional kidney failure. A comparison between 2 different models of inotropic stimulation and diuresis potentiation]. De Vecchis R, Pucciarelli G, Nocerino L, Cocozza M, Setaro A, Torre G, Imperatore F. Minerva Cardioangiol; 1998 May; 46(5):163-74. PubMed ID: 9842199 [Abstract] [Full Text] [Related]
3. Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure. Cotter G, Weissgarten J, Metzkor E, Moshkovitz Y, Litinski I, Tavori U, Perry C, Zaidenstein R, Golik A. Clin Pharmacol Ther; 1997 Aug; 62(2):187-93. PubMed ID: 9284855 [Abstract] [Full Text] [Related]
4. Randomized Evaluation of Heart Failure With Preserved Ejection Fraction Patients With Acute Heart Failure and Dopamine: The ROPA-DOP Trial. Sharma K, Vaishnav J, Kalathiya R, Hu JR, Miller J, Shah N, Hill T, Sharp M, Tsao A, Alexander KM, Gupta R, Montemayor K, Kovell L, Chasler JE, Lee YJ, Fine DM, Kass DA, Weiss RG, Thiemann DR, Ndumele CE, Schulman SP, Russell SD, Osler Medical Housestaff. JACC Heart Fail; 2018 Oct; 6(10):859-870. PubMed ID: 30098962 [Abstract] [Full Text] [Related]
5. Concomitant treatment with urodilatin (ularitide) does not improve renal function in patients with acute renal failure after major abdominal surgery--a randomized controlled trial. Herbert MK, Ginzel S, Mühlschlegel S, Weis KH. Wien Klin Wochenschr; 1999 Feb 26; 111(4):141-7. PubMed ID: 10192146 [Abstract] [Full Text] [Related]
6. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function. De Vecchis R, Ciccarelli A, Ariano C, Cioppa C, Giasi A, Pucciarelli A, Cantatrione S. Minerva Cardioangiol; 2011 Dec 26; 59(6):543-54. PubMed ID: 21330961 [Abstract] [Full Text] [Related]
14. Efficacy and safety of high dose versus low dose furosemide with or without dopamine infusion: the Dopamine in Acute Decompensated Heart Failure II (DAD-HF II) trial. Triposkiadis FK, Butler J, Karayannis G, Starling RC, Filippatos G, Wolski K, Parissis J, Parisis C, Rovithis D, Koutrakis K, Skoularigis J, Antoniou CK, Chrysohoou C, Pitsavos C, Stefanadis C, Nastas J, Tsaknakis T, Mantziari L, Giannakoulas G, Karvounis H, Kalogeropoulos AP, Giamouzis G. Int J Cardiol; 2014 Mar 01; 172(1):115-21. PubMed ID: 24485633 [Abstract] [Full Text] [Related]
15. Effects of ventriculoarterial coupling changes on renal function, echocardiographic indices and energy efficiency in patients with acute decompensated systolic heart failure under furosemide and dopamine treatment: a comparison of three therapeutic protocols. Antoniou CK, Chrysohoou C, Lerakis S, Manolakou P, Pitsavos C, Tsioufis K, Stefanadis C, Tousoulis D. Int J Cardiol; 2015 Nov 15; 199():44-9. PubMed ID: 26186629 [Abstract] [Full Text] [Related]
18. The effect of 'renal-dose' dopamine on renal tubular function following cardiac surgery: assessed by measuring retinol binding protein (RBP). Tang AT, El-Gamel A, Keevil B, Yonan N, Deiraniya AK. Eur J Cardiothorac Surg; 1999 May 15; 15(5):717-21; discussion 721-2. PubMed ID: 10386423 [Abstract] [Full Text] [Related]